Clinical Trial Update: Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of trimipramine, atezolizumab, and bevacizumab in patients with recurrent glioblastoma, and recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• TRIMIPRAMINE (Trimipramine)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Glioblastoma, Recurrence Tumor | Phase 2 | Status: RECRUITING